Bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer: Updated findings from a randomized, multicenter phase III trial

Tarih
2011
Yazar
Buyukberber, S.
Kilickap, S.
Buyukunal, E.
Camci, C.
Sencan, O.
Yalcin, S.
Uslu, R.
Dane, F.
Yilmaz, U.
Zengin, N.
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/153201
https://doi.org/10.1200/jco.2011.29.15_suppl.3579
Koleksiyonlar